IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 395 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,000 | -25.0% | 60 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -55.6% | 60 | -70.0% | 0.00% | -100.0% |
| Q1 2018 | $9,000 | -10.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | -28.6% | 200 | -29.3% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | +75.0% | 283 | +41.5% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | -20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $10,000 | +42.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $7,000 | +40.0% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -37.5% | 200 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $8,000 | -33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $12,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |